These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 31948817)

  • 1. Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth.
    Posuwan N; Wanlapakorn N; Vongpunsawad S; Sintusek P; Leuridan E; Van Damme P; Poovorawan Y
    Vaccine; 2020 Feb; 38(7):1643-1651. PubMed ID: 31948817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age.
    Wanlapakorn N; Pruetarat N; Sarawanangkoor N; Phanphanit K; Srimuan D; Thatsanathorn T; Thongmee T; Posuwan N; Poovorawan Y
    Vaccine; 2023 Jun; 41(26):3855-3861. PubMed ID: 37202270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
    Klein NP; Abu-Elyazeed R; Cheuvart B; Janssens W; Mesaros N
    Hum Vaccin Immunother; 2019; 15(4):809-821. PubMed ID: 30444673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers.
    Martinón-Torres F; Diez-Domingo J; Feroldi E; Jordanov E; B'Chir S; Da Costa X
    Pediatr Infect Dis J; 2019 Mar; 38(3):317-322. PubMed ID: 30408001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody persistence to diphtheria toxoid, tetanus toxoid,
    Wanlapakorn N; Sarawanangkoor N; Srimuan D; Thatsanathorn T; Thongmee T; Poovorawan Y
    Hum Vaccin Immunother; 2024 Dec; 20(1):2352909. PubMed ID: 38752802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration.
    Madhi SA; López P; Zambrano B; Jordanov E; B'Chir S; Noriega F; Feroldi E
    Hum Vaccin Immunother; 2019; 15(3):658-668. PubMed ID: 30513252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
    Schwarz TF; Behre U; Adelt T; Donner M; Suryakiran PV; Janssens W; Mesaros N; Panzer F
    Hum Vaccin Immunother; 2019; 15(1):235-241. PubMed ID: 30118633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity.
    Nolan T; Hogg G; Darcy MA; Skeljo M; Carlin J; Boslego J
    Vaccine; 2001 Feb; 19(15-16):2127-37. PubMed ID: 11228385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months.
    Kosalaraksa P; Chokephaibulkit K; Benjaponpitak S; Pancharoen C; Chuenkitmongkol S; B'Chir S; Da Costa X; Vidor E
    Hum Vaccin Immunother; 2018 May; 14(5):1257-1265. PubMed ID: 29333947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
    Omeñaca F; Vázquez L; Garcia-Corbeira P; Mesaros N; Hanssens L; Dolhain J; Gómez IP; Liese J; Knuf M
    Vaccine; 2018 Feb; 36(7):986-996. PubMed ID: 29336924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.
    Vesikari T; Borrow R; Da Costa X; Richard P; Eymin C; Boisnard F; Lockhart S
    Vaccine; 2017 Jan; 35(3):452-458. PubMed ID: 27939054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
    Tregnaghi M; Zambrano B; Santos-Lima E
    Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.
    Faingezicht I; Avila-Aguerro ML; Cervantes Y; Fourneau M; Clemens SA
    Rev Panam Salud Publica; 2002 Oct; 12(4):247-57. PubMed ID: 12431356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
    Behre U; Van Der Meeren O; Crasta P; Hanssens L; Mesaros N
    Hum Vaccin Immunother; 2016 Nov; 12(11):2916-2920. PubMed ID: 27653771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a liquid hexavalent DTaP-IPV-HB-PRP∼T vaccine after primary and booster vaccination of term and preterm infants born to women vaccinated with Tdap during pregnancy.
    Maertens K; Orije MRP; Huoi C; Boisnard F; Lyabis O
    Vaccine; 2023 Jan; 41(3):795-804. PubMed ID: 36528443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
    López P; Arguedas Mohs A; Abdelnour Vásquez A; Consuelo-Miranda M; Feroldi E; Noriega F; Jordanov E; B Chir S; Zambrano B
    Pediatr Infect Dis J; 2017 Nov; 36(11):e272-e282. PubMed ID: 28719500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand.
    Sanchez L; Rungmaitree S; Kosalaraksa P; Jantarabenjakul W; Leclercq J; Yaiprayoon Y; Midde VJ; Varghese K; Mangarule S; Noriega F
    Pediatr Infect Dis J; 2023 Aug; 42(8):711-718. PubMed ID: 37257121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine.
    Lim FS; Han HH; Jacquet JM; Bock HL
    Ann Acad Med Singap; 2007 Oct; 36(10):801-6. PubMed ID: 17987229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.